[go: up one dir, main page]

GB201702637D0 - Polymeric proteins and uses thereof - Google Patents

Polymeric proteins and uses thereof

Info

Publication number
GB201702637D0
GB201702637D0 GBGB1702637.8A GB201702637A GB201702637D0 GB 201702637 D0 GB201702637 D0 GB 201702637D0 GB 201702637 A GB201702637 A GB 201702637A GB 201702637 D0 GB201702637 D0 GB 201702637D0
Authority
GB
United Kingdom
Prior art keywords
polymeric proteins
proteins
polymeric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GBGB1702637.8A
Other versions
GB2543713A (en
GB2543713B (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Liverpool School of Tropical Medicine
Original Assignee
Liverpool School of Tropical Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liverpool School of Tropical Medicine filed Critical Liverpool School of Tropical Medicine
Publication of GB201702637D0 publication Critical patent/GB201702637D0/en
Publication of GB2543713A publication Critical patent/GB2543713A/en
Application granted granted Critical
Publication of GB2543713B publication Critical patent/GB2543713B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/35—Valency
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/40—Immunoglobulins specific features characterized by post-translational modification
    • C07K2317/41—Glycosylation, sialylation, or fucosylation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
    • C07K2317/524—CH2 domain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
    • C07K2317/53—Hinge
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/94—Stability, e.g. half-life, pH, temperature or enzyme-resistance
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GB1702637.8A 2014-07-18 2015-07-20 Polymeric proteins and uses thereof Active GB2543713B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1412821.9A GB201412821D0 (en) 2014-07-18 2014-07-18 Polymeric proteins and uses thereof
PCT/GB2015/052098 WO2016009232A1 (en) 2014-07-18 2015-07-20 Polymeric proteins and uses thereof

Publications (3)

Publication Number Publication Date
GB201702637D0 true GB201702637D0 (en) 2017-04-05
GB2543713A GB2543713A (en) 2017-04-26
GB2543713B GB2543713B (en) 2019-03-27

Family

ID=51494824

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB1412821.9A Ceased GB201412821D0 (en) 2014-07-18 2014-07-18 Polymeric proteins and uses thereof
GB1702637.8A Active GB2543713B (en) 2014-07-18 2015-07-20 Polymeric proteins and uses thereof

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GBGB1412821.9A Ceased GB201412821D0 (en) 2014-07-18 2014-07-18 Polymeric proteins and uses thereof

Country Status (2)

Country Link
GB (2) GB201412821D0 (en)
WO (1) WO2016009232A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2846024T7 (en) 2015-07-24 2023-06-22 Gliknik Inc Fusion Proteins of Human Protein Fragments to Create Orderly Multimerized Immunoglobulin Fc Compositions with Enhanced Complement Binding
CA3026420A1 (en) 2016-06-07 2017-12-14 Gliknik Inc. Cysteine-optimized stradomers
EP3487534A4 (en) 2016-07-22 2020-03-25 Gliknik Inc. Fusion proteins of human protein fragments to create orderly multimerized immunoglobulin fc compositions with enhanced fc receptor binding
IL266988B2 (en) 2016-12-09 2024-11-01 Gliknik Inc Methods for the treatment of inflammatory disorders with multivalent FC compounds
CN112236449A (en) * 2018-03-16 2021-01-15 利物浦热带医学院 Chimeric FC receptor binding proteins and uses thereof
MX2023015461A (en) * 2021-06-17 2024-01-18 Fapon Biotech Inc Chimeric immunoglobulin.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0922209D0 (en) * 2009-12-18 2010-02-03 Univ Nottingham Proteins, nucleic acid molecules and compositions

Also Published As

Publication number Publication date
GB201412821D0 (en) 2014-09-03
WO2016009232A1 (en) 2016-01-21
GB2543713A (en) 2017-04-26
GB2543713B (en) 2019-03-27

Similar Documents

Publication Publication Date Title
IL275307B (en) Syntac polypeptides and uses thereof
IL252804B (en) Anti-c10orf54 antibodies and uses thereof
IL251248A0 (en) Anti-interleukin-33 antibodies and uses thereof
ZA201605894B (en) Anti-egfrviii antibodies and uses thereof
IL247014A0 (en) 6-heteroaryloxy- and 6-aryloxy-quinoline-2-carboxamides and uses thereof
HUE044571T2 (en) Modified cyclopentapeptides and uses thereof
ZA201701663B (en) Anti-il-25 antibodies and uses thereof
IL297057B2 (en) Combinations and uses thereof
GB2543713B (en) Polymeric proteins and uses thereof
GB201410031D0 (en) Polypeptides and uses thereof
IL254241A0 (en) Etv2 and uses thereof
EP3209697A4 (en) Fn14-binding proteins and uses thereof
SG11201610918RA (en) Peptides and uses thereof
GB201617925D0 (en) Proteins and uses